A recommended scale for cognitive screening in clinical trials of Parkinson's disease

Movement Disorders

Volumn 25, Issue 15, 2010, Pages 2501-2507

  Chou, Kelvin L ^a,p   Amick, Melissa M ^b   Brandt, Jason ^c   Camicioli, Richard ^d   Frei, Karen ^e   Gitelman, Darren ^f   Goldman, Jennifer ^g   Growdon, John ^h   Hurtig, Howard I ⁱ   Levin, Bonnie ^j   Litvan, Irene ^k   Marsh, Laura ^l   Simuni, Tanya ^f   Tröster, Alexander I ^m   Uc, Ergun Y ^n,o  

^a UNIVERSITY OF MICHIGAN   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e Parkinson's and Movement Disorder Institute   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^k University of Louisville School of Medicine   (United States)

^l BAYLOR COLLEGE OF MEDICINE   (United States)

^m UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF IOWA   (United States)

^o VETERANS AFFAIRS MEDICAL CENTER   (United States)

^p UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

more..

Author keywords

Cognitive impairment; Cognitive screening; Parkinson's disease

Indexed keywords

ARTICLE; ATTENTION; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DIAGNOSTIC TEST; HUMAN; LANGUAGE ABILITY; MILD COGNITIVE IMPAIRMENT; MINI MENTAL PARKINSON; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PARKINSON DISEASE; PARKINSON NEUROPSYCHOMETRIC DEMENTIA ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOMETRY; RATING SCALE; SCALES FOR OUTCOME IN PARKINSONS DISEASE COGNITION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYMPTOM;

CLINICAL TRIALS AS TOPIC; COGNITION; COGNITION DISORDERS; HUMANS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHOMETRICS; QUESTIONNAIRES;

EID: 78349233086     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23362     Document Type: Article

References (33)

1. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008; 23: 837-844.
2. Kulisevsky J, Pagonabarraga J. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment. Mov Disord 2009; 24: 1103-1110.
3. Reyes MA, Lloret SP, Gerscovich ER, Martin ME, Leiguarda R, Merello M. Addenbrooke's Cognitive Examination validation in Parkinson's disease. Eur J Neurol 2009; 16: 142-147.
4. Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry 1994; 151: 390-396.
5. Hobson P, Meara J. The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test. Age Ageing 1999; 28: 39-43.
6. Mattis S. Dementia Rating Scale professional manual. Odessa, FL: Psychological Assessment Resources; 1988.
7. Mahieux F, Michelet D, Manifacier M-J, Boller F, Fermanian J, Guillard A. Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson's disease. Behav Neurol 1995; 8: 15-22.
8. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
9. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699.
10. Pagonabarraga J, Kulisevsky J, Llebaria G, Garcia-Sanchez C, Pascual-Sedano B, Gironell A. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease. Mov Disord 2008; 23: 998-1005.
11. Kalbe E, Calabrese P, Kohn N, et al. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism Relat Disord 2008; 14: 93-101.
12. Marinus J, Visser M, Verwey NA, et al. Assessment of cognition in Parkinson's disease. Neurology 2003; 61: 1222-1228.
13. Ferris SH. Cognitive outcome measures. Alzheimer Dis Assoc Disord 1999; 13(suppl 3): S140-S142.
14. Athey RJ, Porter RW, Walker RW. Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R). Age Ageing 2005; 34: 268-273.
15. Llebaria G, Pagonabarraga J, Kulisevsky J, et al. Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease. Mov Disord 2008; 23: 1546-1550.
16. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 1992; 40: 922-935.
17. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993; 269: 2386-2391.
18. Aarsland D, Andersen K, Larsen JP, et al. The rate of cognitive decline in Parkinson disease. Arch Neurol 2004; 61: 1906-1911.
19. Aarsland D, Laake K, Larsen JP, Janvin C. Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 2002; 72: 708-712.
20. Muller T, Welnic J, Fuchs G, Baas H, Ebersbach G, Reichmann H. The DONPAD-study-treatment of dementia in patients with Parkinson's disease with donepezil. J Neural Transm Suppl 2006: 27-30.
21. Wind AW, Schellevis FG, Van Staveren G, Scholten RP, Jonker C, Van Eijk JT. Limitations of the Mini-Mental State Examination in diagnosing dementia in general practice. Int J Geriatr Psychiatry 1997; 12: 101-108.
22. Gill DJ, Freshman A, Blender JA, Ravina B. The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease. Mov Disord 2008; 23: 1043-1046.
23. Zadikoff C, Fox SH, Tang-Wai DF, et al. A comparison of the Mini Mental State Exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. Mov Disord 2008; 23: 297-299.
24. Nazem S, Siderowf AD, Duda JE, et al. Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to Mini-Mental State Examination score. J Am Geriatr Soc 2009; 57: 304-308.
25. Hoops S, Nazem S, Siderowf AD, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009; 73: 1738-1745.
26. Di Virgilio G, Leroy A, Cunin P, Mahieux F, Bachoud-Levi A-C, Fenelon G. The Mini Mental Parkinson brief cognitive test: comparison with the Mattis dementia rating scale in 289 patients with Parkinson's disease. Mov Disord 2007; 22(suppl 16): S89-S90.
27. Riedel O, Klotsche J, Spottke A, et al. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol 2008; 255: 255-264.
28. Carod-Artal FJ, Martinez-Martin P, Kummer W, Ribeiro Lda S. Psychometric attributes of the SCOPA-COG Brazilian version. Mov Disord 2008; 23: 81-87.
29. Verbaan D, Marinus J, Visser M, et al. Cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78: 1182-1187.
30. Pagonabarraga J, Kulisevsky J, Llebaria G, et al. PDD-Short Screen: a brief cognitive test for screening dementia in Parkinson's disease. Mov Disord 2010; 25: 440-446.
31. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22: 1689-1707; quiz 1837.
32. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007; 22: 2314-2324.
33. Uc EY, McDermott MP, Marder KS, et al. Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Neurology 2009; 73: 1469-1477.